MX9203173A - Composicion farmaceutica de liberacion controlada, equilibrada hidrodinamicamente. - Google Patents

Composicion farmaceutica de liberacion controlada, equilibrada hidrodinamicamente.

Info

Publication number
MX9203173A
MX9203173A MX9203173A MX9203173A MX9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A
Authority
MX
Mexico
Prior art keywords
hydrodynamically
balanced
pharmaceutical composition
controlled release
release
Prior art date
Application number
MX9203173A
Other languages
English (en)
Spanish (es)
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9203173A publication Critical patent/MX9203173A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9203173A 1981-09-14 1992-06-23 Composicion farmaceutica de liberacion controlada, equilibrada hidrodinamicamente. MX9203173A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (1)

Publication Number Publication Date
MX9203173A true MX9203173A (es) 1992-07-01

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203173A MX9203173A (es) 1981-09-14 1992-06-23 Composicion farmaceutica de liberacion controlada, equilibrada hidrodinamicamente.

Country Status (11)

Country Link
JP (1) JPS5857315A (fr)
AT (1) AT385199B (fr)
BE (1) BE894376A (fr)
BG (1) BG60526B2 (fr)
CH (1) CH652025A5 (fr)
DE (1) DE3232873A1 (fr)
FR (1) FR2512676B1 (fr)
GB (1) GB2105590B (fr)
IT (1) IT1158048B (fr)
MX (1) MX9203173A (fr)
NL (1) NL190746C (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (fr) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Compositions thérapeutiques flottantes à libération prolongée
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DE3642668A1 (de) * 1986-12-13 1988-06-23 Kamprad Joachim Schmerzmittel fuer menschen
EP0324947B2 (fr) * 1987-12-31 1997-08-20 ASTA Medica Aktiengesellschaft Combinaison synergique d'inhibiteurs de décarboxylase et de pilules de L-Dopa
ATE119766T1 (de) * 1989-10-26 1995-04-15 Nippon Shinyaku Co Ltd Zubereitung für den magen.
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
NZ274901A (en) * 1993-10-29 1997-03-24 Reckitt & Colmann Prod Ltd Chewable gelatin capsule for the treatment of gastric reflux or peptic ulceration comprising polymeric material, carbonate or bicarbonate salt and oil or hydrophilic based liquid vehicle
WO1995011667A1 (fr) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Substance a pouvoir moussant garnissant une gelule de gelatine
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
EP1560569A4 (fr) * 2002-10-11 2006-03-22 Depomed Dev Ltd Forme gastro-retentive pour administrer du levodopa
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
DE102014003744A1 (de) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (de) * 1961-06-16 1966-03-31 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinen
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
CH652025A5 (de) 1985-10-31
DE3232873A1 (de) 1983-03-31
GB2105590A (en) 1983-03-30
FR2512676B1 (fr) 1987-01-23
JPH0341447B2 (fr) 1991-06-24
AT385199B (de) 1988-02-25
GB2105590B (en) 1985-05-30
FR2512676A1 (fr) 1983-03-18
NL190746B (nl) 1994-03-01
JPS5857315A (ja) 1983-04-05
BG60526B2 (bg) 1995-07-28
BE894376A (fr) 1983-03-14
ATA341582A (de) 1987-08-15
NL190746C (nl) 1994-08-01
IT8223147A0 (it) 1982-09-07
IT1158048B (it) 1987-02-18
NL8203343A (nl) 1983-04-05

Similar Documents

Publication Publication Date Title
MX9203173A (es) Composicion farmaceutica de liberacion controlada, equilibrada hidrodinamicamente.
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
ES524186A0 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
ES517862A0 (es) Derivados de alcanosulfonanilida.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES522446A0 (es) Procedimiento para la preparacion de alfa-halobencil-alfa-(3-piridil o 2-pirizinil)-alcanoles.
ES516863A0 (es) Procedimiento para la preparacion de derivados de penem.
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
AR227335A1 (es) Procedimiento para la preparacion de alfa-(3,4,5-trimetoxibenzoiltio)-propionilglicina
ES509761A0 (es) "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas".
ES513974A0 (es) Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol.
ES519351A0 (es) Procedimiento para la preparacion de benzotriazoles.
ES510963A0 (es) Procedimiento de preparacion de alcoxiaminohidridosilanos.
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
ES511914A0 (es) Derivados de isoquinolina 1,5-sustituidos.
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.
MX159206A (es) Procedimiento para preparar derivados de 20,21 dinoreburnamenina
NL193821B (nl) Farmaceutisch preparaat.
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
ES521597A0 (es) Procedimiento de preparacion de compuestos piridotienopiridacinicos.